No association between catechol-o-methyltransferase Val108/158Met polymorphism and schizophrenia or its clinical symptomatology in a Mexican population

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 2053-2058

  Tovilla Zárate, Carlos ^a   Medellín, Beatriz Camarena ^b   Fresán, Ana ^b   López Narváez, Lilia ^c   Castro, Thelma Beatriz Gonzalez ^a   Juárez Rojop, Isela ^a   Ramírez Bello, Julián ^d   Genis, Alma ^e   Nicolini, Humberto ^e  

^a UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^c CIGEN   (Mexico)

^d INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^e Grupo de Estudios Médicos y Familiares Carracci   (Mexico)

Author keywords

Association; Clinical symptomatology; COMT; Mexican population; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CATECHOL O METHYLTRANSFERASE GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DSM-IV; FEMALE; GENOTYPE; HEBEPHRENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; PSYCHOSIS; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84878350780     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2264-x     Document Type: Article

References (41)

1. McGrath J, Saha S, Chant D, Welham J (2008) Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67-76
2. Vereczkei A, Mirnics K (2011) Genetic predisposition to schizophrenia: what did we learn and what does the future hold? Neuropsychopharmacol Hung 13(4):205-210
3. Sullivan PF, Daly MJ, O'Donovan M (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13 (8):537-551. http://www.nature.com/nrg/journal/v13/n8/suppinfo/nrg3240-S1. html
4. Sagud M, Muck-Seler D, Mihaljevic-Peles A, Vuksan-Cusa B, Zivkovic M, Jakovljevic M, Pivac N (2010) Catechol-O-methyl transferase and schizophrenia. Psychiatr Danub 22(2):270-274
5. van Haren NE, Bakker SC, Kahn RS (2008) Genes and structural brain imaging in schizophrenia. Curr Opin Psychiatry 21(2):161-167
6. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6(3):243-250
7. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC, Spurlock G, Riley B, Scambler P, Asherson P, McGuffin P, Owen MJ (1996) No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 153(2):268-270
8. Liou YJ, Tsai SJ, Hong CJ, Wang YC, Lai IC (2001) Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan. Neuropsychobiology 43(1):11-14. doi: nps43011 [pii]
9. Norton N, Kirov G, Zammit S, Jones G, Jones S, Owen R, Krawczak M, Williams NM, O'Donovan MC, Owen MJ (2002) Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am J Med Genet 114(5):491-496. doi: 10.1002/ajmg.10517
10. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71(6):1296-1302. doi: 10.1086/344514
11. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM (1997) Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69(2-3):71-77. doi: S0165-1781(96)03111-3
12. Wonodi I, Stine OC, Mitchell BD, Buchanan RW, Thaker GK (2003) Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 120B(1):47-50. doi: 10.1002/ajmg.b.20037
13. Wan CL, Zainal NZ, Lian LH, Mohamed Z (2011) Association of the functional polymorphism in the catechol-O-methyltransferase gene with schizophrenia in the three ethnic groups of the Malaysian population. Psychiatry Res 189(1):67-71
14. Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP (2012) HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association. Eur Psychiatry 27(5):372-376
15. Hoenicka J, Garrido E, Martinez I, Ponce G, Aragues M, Rodriguez-Jimenez R, Espana-Serrano L, Alvira-Botero X, Santos JL, Rubio G, Jimenez-Arriero MA, Palomo T (2010) Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 5(1):79-85
16. Wang Y, Fang Y, Shen Y, Xu Q (2010) Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia. Psychiatry Res 179(2):147-150
17. Han DH, Kee BS, Min KJ, Lee YS, Na C, Park DB, Lyoo IK (2006) Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 17(1):95-99
18. Molero P, Ortuno F, Zalacain M, Patino-Garcia A (2007) Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Pharmacogenomics J 7(6):418-426. doi: 10.1038/sj.tpj.6500441
19. Li WJ, Kou CG, Yu Y, Sun S, Zhang X, Kosten TR, Zhang XY (2012) Association of catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population. Am J Med Genet B Neuropsychiatr Genet 4:370-375
20. Chen CY, Lu RB, Yeh YW, Shih MC, Huang SY (2011) Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes Brain Behav 10(3):316-324
21. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X, Goldman RS, Hoptman MJ, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Kunz M, Chakos M, Cooper TB, Lieberman JA (2002) Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52(7):701-707. doi: S0006322302014166 [pii]
22. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98(12):6917-6922. doi: 10.1073/pnas.111134598 [pii]
23. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, Benkelfat C, Labelle A (2002) Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 59(7):662-663 ylt0702-2 [pii]
24. Inada T, Nakamura A, Iijima Y (2003) Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet B Neuropsychiatr Genet 120B(1):35-39. doi: 10.1002/ajmg.b.20023
25. Strous RD, Lapidus R, Viglin D, Kotler M, Lachman HM (2006) Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Neurosci Lett 393(2-3):170-173. doi: 10.1016/j.neulet.2005.09.067 [pii]
26. Tsai SJ, Hong CJ, Liao DL, Lai IC, Liou YJ (2004) Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Neuropsychobiology 49(4):196-200
27. Andreasen N (1983) The scale for the assessment of negative symptoms (SANS). University of Iowa, Iowa City
28. Andreasen N (1984) The scale for the assessment of positive symptoms (SAPS). University of Iowa, Iowa City
29. Pelayo-Teran JM, Crespo-Facorro B, Carrasco-Marin E, Perez-Iglesias R, Mata I, Arranz MJ, Leyva-Cobian F, Vazquez-Barquero JL (2008) Catechol-O-methyltransferase Val158Met polymorphism and clinical characteristics in first episode non-affective psychosis. Am J Med Genet B Neuropsychiatr Genet 147B(5):550-556. doi: 10.1002/ajmg.b.30639
30. Grube BS, Bilder RM, Goldman RS (1998) Meta-analysis of symptom factors in schizophrenia. Schizophr Res 31(2-3):113-120
31. Lahiri DK, Nurnberger JI Jr (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19(19):5444
32. Tovilla-Zarate C, Juarez-Rojop I, Ramon-Frias T, Villar-Soto M, Pool-Garcia S, Medellin BC, Genis Mendoza AD, Narvaez LL, Humberto N (2011) No association between COMT val158met polymorphism and suicidal behavior: meta-analysis and new data. BMC Psychiatry 11:151. doi: 10.1186/1471-244X-11-151
33. Nieratschker V, Frank J, Muhleisen TW, Strohmaier J, Wendland JR, Schumacher J, Treutlein J, Breuer R, Abou Jamra R, Mattheisen M, Herms S, Schmal C, Maier W, Nothen MM, Cichon S, Rietschel M, Schulze TG (2010) The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample. Schizophr Res 122(1-3):24-30. doi: 10.1016/j.schres.2010.06.018
34. Okochi T, Ikeda M, Kishi T, Kawashima K, Kinoshita Y, Kitajima T, Yamanouchi Y, Tomita M, Inada T, Ozaki N, Iwata N (2009) Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 110(1-3):140-148. doi: 10.1016/j.schres.2009.02.019
35. Munafo MR, Bowes L, Clark TG, Flint J (2005) Lack of association of the COMT (Val(158/108) Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 10(8):765-770. doi: 10.1038/sj.mp.4001664
36. Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, Feng GY, Clair DS, He L (2005) Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 57(2):139-144. doi: 10.1016/j.biopsych.2004.10.018
37. Costas J, Sanjuan J, Ramos-Rios R, Paz E, Agra S, Ivorra JL, Paramo M, Brenlla J, Arrojo M (2011) Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. J Psychiatr Res 45(1):7-14. doi: 10.1016/j.jpsychires.2010.04.021
38. Woo SI, Il Moon H, Lee YJ, Park BL, Shin HD (2009) Association analysis of polymorphisms on catechol-O-methyl transferase (COMT) gene with schizophrenia in the Korean population. Biol Psychiatry 65(8):201S
39. Pelayo-Teran JM, Perez-Iglesias R, Mata I, Carrasco-Marin E, Vazquez-Barquero JL, Crespo-Facorro B (2010) Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications. Psychiatry Res 179(3):291-296. doi: 10.1016/j.psychres.2009.08.022
40. Tovilla-Zarate C, Camarena B, Apiquian R, Nicolini H (2008) Association study and meta-analysis of the apolipoprotein gene and schizophrenia. Gac Med Mex 144(2):79-83
41. Tiwary BK (2012) The severity of mental disorders is linked to interaction among candidate genes. Integr Biol 9:9